Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01996306
Brief Title: A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (AXEPT)

First Submitted : November 22, 2013
First Submitted that Met QC Criteria : November 22, 2013
First Posted : November 27, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : January 6, 2019
Last Update Posted : January 8, 2019